Canada's Psychedelic Future

Published on

Canada’s growing reputation as a world leader in medical and recreational cannabis research has now spilled over into psychedelics. Because of Canada’s lax regulatory environment, researchers from around the world are flocking to our country to study how psychedelic compounds like LSD, psilocybin (the compound found in magic mushrooms), and MDMA (commonly known as ecstasy) can be used to treat mental health disorders such as depression and anxiety.

Advertising
To be informed of the latest articles, subscribe:
Comment on this post